SILO PHARMA

Serial Number 90249449
734

Registration Progress

Application Filed
Oct 12, 2020
Under Examination
Jan 17, 2023
Approved for Publication
Nov 22, 2022
Published for Opposition
Nov 22, 2022
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 17, 2026 20 days
Statement of Use required (all extensions used)

Trademark Image

SILO PHARMA

Basic Information

Serial Number
90249449
Filing Date
October 12, 2020
Published for Opposition
November 22, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Dec 16, 2025
Application
Pending
Classes
042

Rights Holder

Silo Pharma, Inc

03
Address
560 Sylvan Avenue, Suite 3160
Englewood Cliffs, NJ 07632

Ownership History

Silo Pharma, Inc

Original Applicant
03
Wilmington, DE

Silo Pharma, Inc

Owner at Publication
03
Englewood Cliffs, NJ

Legal Representation

Attorney
Paul Garrity

USPTO Deadlines

Next Deadline
20 days remaining
NOA E-Mailed - SOU Required
Due Date
January 17, 2026

Application History

44 events
Date Code Type Description Documents
Dec 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 16, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 15, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 18, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 18, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 17, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 17, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 17, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 16, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 16, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 14, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 14, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 17, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 13, 2022 ALIE A ASSIGNED TO LIE Loading...
Sep 2, 2022 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Mar 2, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 2, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 2, 2022 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 1, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 31, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 31, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 30, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 30, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 30, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 22, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 16, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 29, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 15, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Biological research; Laboratory research services relating to pharmaceuticals; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Product research and development; none of the foregoing services involving the sale, manufacture, distribution, delivery, dispensing, possession, or provision of a controlled substance

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"